# Siimon Vaske

> Siimon Vaske is a seed investor at Trio Impact Invest backing Biotechnology and Biopharma. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Trio Impact Invest](https://shizune.co/investors/profile/trio-impact-invest)
- Total investments: 3
- Last investment: Jul 2026
- Lead investor: 100%
- Last updated: Aug 2026

Siimon Vaske is a seed investor at Trio Impact Invest focused on Biotechnology and Biopharma.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 67% |
| Biopharma | 1 | 33% |
| CleanTech | 1 | 33% |
| Clean Energy | 1 | 33% |
| Pharmaceutical | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Pre-Seed | 1 | 33% |
| Venture - Series Unknown | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Caplyzer | Caplyzer develops and patented a new solution for water electrolysis. | $726.6K | Seed | Jul 07, 2026 |  |
| GenomeVault | GenomeVault is a biodiversity startup that converts eDNA from nature into scalable biodiversity insights using advanced genomics. | $515.3K | Pre-Seed | Jul 07, 2026 |  |
| AAX Biotech | AAX Biotech specializes in next-generation antibody therapeutics through our two unique and proprietary technologies, Seqitope™ and Opti-mAb™, that enable high-resolution and high throughput epitope mapping as well as stabilization of single chain variable fragments (scFv) for applications such as bispecific antibodies and CAR-T cells. OurTechnologies: Seqitope™ is a high-resolution, high throughput method for antibody epitope mapping that accelerates the development of efficacious therapeutics.Opti-mAb™ is a new scFv format with dramatically improved expression levels and reduced aggregation tendencies. This will significantly improve the next generation of cutting-edge immunotherapies such as CAR-T and bispecific antibodies. |  | Venture - Series Unknown | Feb 19, 2026 |  |

3 of 3 investments shown.

## Co-investors
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund, 1 deal together
- [Karolinska Institutet Innovation](https://shizune.co/investors/profile/karolinska-institutet-innovation) — VC Fund, 1 deal together
- [KTH Ventures](https://shizune.co/investors/profile/kth-ventures) — VC Fund, 1 deal together
- [Singularity University Ventures](https://shizune.co/investors/profile/singularity-university-ventures) — VC Fund, 1 deal together
- [Uppsala universitet Invest AB](https://shizune.co/investors/profile/uppsala-universitet-invest-ab) — VC Fund, 1 deal together

## About Trio Impact Invest

VC Fund

Trio Impact Invest is a venture capital investment firm.

1 contacts available at Trio Impact Invest.

| Name | Title | Profile |
| --- | --- | --- |
| Siimon Vaske | Fund Manager and Chief Executive Officer | https://shizune.co/investors/profile/siimon-vaske-4187 |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Siimon Vaske invest in?

Siimon Vaske invests primarily in Biotechnology, Biopharma and CleanTech startups, most often at Seed and Pre-Seed stage. Most of the 3 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Siimon Vaske last invest?

The most recent investment recorded for Siimon Vaske closed in Jul 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co